• Je něco špatně v tomto záznamu ?

Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study

G. Palareti, A. Bignamini, M. Cini, YJ. Li, T. Urbanek, J. Madaric, K. Bouslama, GY. Sokurenko, GM. Andreozzi, J. Matuška, A. Mansilha, V. Barinov, WHITE study group

. 2022 ; 17 (1) : 71-82. [pub] 20210727

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019537
E-zdroje Online Plný text

NLK ProQuest Central od 2006-04-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2006-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2006-04-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2006-04-01 do Před 1 rokem
Family Health Database (ProQuest) od 2006-04-01 do Před 1 rokem

Odkazy

PubMed 34313959
DOI 10.1007/s11739-021-02765-1
Knihovny.cz E-zdroje

The decision on treatment after a first venous thromboembolism (VTE) to prevent recurrences may be influenced by many factors. The prospective, observational, WHITE study aimed to analyze how this issue was tackled in every-day clinical practice in various countries, which have sensibly different socio-economic conditions and healthcare systems. Doctors active in 79 Internal or Vascular clinical centers in 7 countries (China, Czechia, Poland, Portugal, Russia, Slovakia, and Tunisia) enrolled VTE patients after the maintenance treatment phase. The present report analyzed information, collected in the central database, regarding the baseline characteristics, index events, type and duration of anticoagulant therapy and decision on post-maintenance treatment. From April 2018 to December 2020, 1240 patients were enrolled, 58% with an unprovoked index event. Direct oral anticoagulants (DOACs) were used in > 85% of all cases in China, Poland, Portugal, Russia and Czechia, in 52% in Slovakia and in no patient in Tunisia. The maintenance anticoagulation lasted in average approximately 6 months. Altogether, anticoagulation was stopped in 20%, extended in about 50%, regardless of whether the event was unprovoked or provoked and shifted to antithrombotics (mainly sulodexide or aspirin) in the remaining patients. In conclusion, some differences in VTE patient management were found between countries. The provoked/unprovoked nature of the index event, instead, was not the prevalent criterion to drive the decision on extension of anticoagulation, without large variations between countries. DOACs were the most widely used anticoagulant drugs, whereas > 25% of patients received antithrombotic drugs instead of anticoagulants as extended treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019537
003      
CZ-PrNML
005      
20220804135741.0
007      
ta
008      
220720s2022 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11739-021-02765-1 $2 doi
035    __
$a (PubMed)34313959
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Palareti, Gualtiero $u Arianna Anticoagulazione Foundation, Via Paolo Fabbri 1/3, 401138, Bologna, Italy. Gualtiero.palareti@unibo.it $1 https://orcid.org/0000000243279561
245    10
$a Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study / $c G. Palareti, A. Bignamini, M. Cini, YJ. Li, T. Urbanek, J. Madaric, K. Bouslama, GY. Sokurenko, GM. Andreozzi, J. Matuška, A. Mansilha, V. Barinov, WHITE study group
520    9_
$a The decision on treatment after a first venous thromboembolism (VTE) to prevent recurrences may be influenced by many factors. The prospective, observational, WHITE study aimed to analyze how this issue was tackled in every-day clinical practice in various countries, which have sensibly different socio-economic conditions and healthcare systems. Doctors active in 79 Internal or Vascular clinical centers in 7 countries (China, Czechia, Poland, Portugal, Russia, Slovakia, and Tunisia) enrolled VTE patients after the maintenance treatment phase. The present report analyzed information, collected in the central database, regarding the baseline characteristics, index events, type and duration of anticoagulant therapy and decision on post-maintenance treatment. From April 2018 to December 2020, 1240 patients were enrolled, 58% with an unprovoked index event. Direct oral anticoagulants (DOACs) were used in > 85% of all cases in China, Poland, Portugal, Russia and Czechia, in 52% in Slovakia and in no patient in Tunisia. The maintenance anticoagulation lasted in average approximately 6 months. Altogether, anticoagulation was stopped in 20%, extended in about 50%, regardless of whether the event was unprovoked or provoked and shifted to antithrombotics (mainly sulodexide or aspirin) in the remaining patients. In conclusion, some differences in VTE patient management were found between countries. The provoked/unprovoked nature of the index event, instead, was not the prevalent criterion to drive the decision on extension of anticoagulation, without large variations between countries. DOACs were the most widely used anticoagulant drugs, whereas > 25% of patients received antithrombotic drugs instead of anticoagulants as extended treatment.
650    _2
$a antikoagulancia $x škodlivé účinky $7 D000925
650    _2
$a hemokoagulace $7 D001777
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    _2
$a recidiva $7 D012008
650    _2
$a rizikové faktory $7 D012307
650    12
$a žilní tromboembolie $x farmakoterapie $x prevence a kontrola $7 D054556
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Bignamini, Angelo $u School of Specialization in Hospital Pharmacy, University of Milan, Milan, Italy
700    1_
$a Cini, Michela $u Arianna Anticoagulazione Foundation, Via Paolo Fabbri 1/3, 401138, Bologna, Italy
700    1_
$a Li, Young-Jun $u Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
700    1_
$a Urbanek, Tomasz $u Medical University of Silesia, Katowice, Poland
700    1_
$a Madaric, Juraj $u Clinic of Angiology, Comenius University and National Institute of Cardiovascular Diseases, Bratislava, Slovakia
700    1_
$a Bouslama, Kamel $u Faculty of Medicine of Tunis, Tunis, Tunisia
700    1_
$a Sokurenko, German Y $u North-West Mechnikov State Medical University, St. Petersburg, Russia
700    1_
$a Andreozzi, Giuseppe M $u Angiology Unit, University of Padua, Padua, Italy
700    1_
$a Matuška, Jiří $u Clinical Trial Centre, Hodonin, Czech Republic
700    1_
$a Mansilha, Armando $u Faculty of Medicine, University of Porto, Porto, Portugal
700    1_
$a Barinov, Victor $u Central State Medical Academy of the Office of the President of the Russian Federation, Clinical hospital N. 1 "Volynskaya", Moscow, Russia
710    2_
$a WHITE study group
773    0_
$w MED00188089 $t Internal and emergency medicine $x 1970-9366 $g Roč. 17, č. 1 (2022), s. 71-82
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34313959 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135735 $b ABA008
999    __
$a ok $b bmc $g 1822939 $s 1170780
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 17 $c 1 $d 71-82 $e 20210727 $i 1970-9366 $m Internal and emergency medicine $n Intern Emerg Med $x MED00188089
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace